In a recent announcement, the National Health Service (NHS) in England declared a significant policy change regarding the prescription of puberty blockers for children seeking gender transition. Effective immediately, doctors are prohibited from prescribing puberty blockers to facilitate gender transition in minors.
Citing insufficient evidence of safety and clinical effectiveness, the NHS update states that “puberty blockers are not available to children and young people for gender incongruence or gender dysphoria.” The decision comes as a result of growing concerns regarding the long-term effects and potential risks associated with these medications.
Puberty blockers halt natural hormonal changes during puberty, impeding developments such as height, breast, and facial hair growth. The NHS emphasizes the importance of caution, urging children, young people, and their families to refrain from obtaining these medications from unregulated sources or online providers not sanctioned by U.K. regulatory bodies.
This policy revision marks a significant shift in the approach to gender-affirming treatments for minors within the public health care system in England, reflecting ongoing debates surrounding the appropriate medical interventions for individuals experiencing gender dysphoria.
Source: CNA
FIND OUT MORE